DWTX

Dogwood Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for serious diseases with significant unmet medical needs. The company's pipeline includes novel therapeutic candidates targeting various conditions, with a focus on precision medicine approaches. As a development-stage company, Dogwood is advancing its drug candidates through clinical trials and regulatory processes. The company does not yet have any commercialized products and generates no product revenue.